Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed)

archived

The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to a consultative resource for planning activities and concept development for single or multi-site investigator initiated clinical trials that address gaps in pediatric drug development and that align with priorities identified in the Best Pharmaceuticals for Children Act (BPCA) Program. The FOA will support the development of clinical trials concepts of future well-designed clinical trials that require non-traditional designs in pediatric therapeutics with the opportunity to expand novelty and/or innovation. Investigators will have access to the expertise in pediatric drug development trial designs by utilizing the consultative services provided by the Pediatric Trials Network (PTN) and the BPCA Data Coordinating Center.

High